THOMAS W BURKE to Adenocarcinoma
This is a "connection" page, showing publications THOMAS W BURKE has written about Adenocarcinoma.
Connection Strength
0.364
-
Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 2009 May 01; 115(9):1867-74.
Score: 0.093
-
Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin. Gynecol Oncol. 1993 Dec; 51(3):397-400.
Score: 0.032
-
Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Gynecol Oncol. 1991 Mar; 40(3):264-7.
Score: 0.026
-
Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma. Gynecol Oncol. 1987 Nov; 28(3):312-7.
Score: 0.021
-
Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma. Obstet Gynecol. 1987 Mar; 69(3 Pt 1):382-5.
Score: 0.020
-
Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol. 1987 Feb; 26(2):153-9.
Score: 0.020
-
Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma. Int J Gynecol Pathol. 2003 Jul; 22(3):297-302.
Score: 0.015
-
Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer. Int J Gynecol Cancer. 2002 Nov-Dec; 12(6):755-9.
Score: 0.015
-
Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol. 2001 Jul; 82(1):150-5.
Score: 0.013
-
Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol. 1998 Aug; 70(2):241-6.
Score: 0.011
-
A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium. Gynecol Oncol. 1996 Oct; 63(1):25-7.
Score: 0.010
-
Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol. 1996 Jul; 88(1):82-6.
Score: 0.010
-
Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol. 1995 Oct; 59(1):38-44.
Score: 0.009
-
Treatment of endometrial carcinoma with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1993 Nov 15; 27(4):817-24.
Score: 0.008
-
Prognostic factors for patients undergoing simple hysterectomy in the presence of invasive cancer of the cervix. Gynecol Oncol. 1993 Aug; 50(2):179-84.
Score: 0.008
-
Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol. 1993 Apr; 49(1):19-23.
Score: 0.008
-
Reasons for inappropriate simple hysterectomy in the presence of invasive cancer of the cervix. Obstet Gynecol. 1992 Apr; 79(4):485-9.
Score: 0.007
-
Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter. Gynecol Oncol. 1991 Jun; 41(3):199-205.
Score: 0.007
-
Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol. 1990 Dec; 76(6):1020-4.
Score: 0.006
-
Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol Oncol. 1990 Dec; 39(3):337-46.
Score: 0.006
-
Treatment failure in endometrial carcinoma. Obstet Gynecol. 1990 Jan; 75(1):96-101.
Score: 0.006
-
Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma. Obstet Gynecol. 1989 Dec; 74(6):930-3.
Score: 0.006
-
Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005 Mar; 105(3):575-80.
Score: 0.004
-
Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol Oncol. 1994 Oct; 55(1):29-35.
Score: 0.002